Vivani Medical Announces Positive Preclinical Weight Loss Data for NPM-139 Semaglutide Implant, with Potential for Once-Yearly Dosing
NanoPortal™ technology successfully delivers semaglutide, the active ingredient in Ozempic®/Wegovy®, in a preclinical study ...
Which Side Will Makary Take In The Fight Over Weight Loss Drugs?
Billions of dollars in annual revenue and the health of millions of patients are at stake in a drug industry battle over who ...